thesun.ng on MSN

I went into medical aesthetics to get solution to my skin issues —Bimbola Ige, founder, Celeb Laser and Aesthetics Clinic

We’re working to professionalise medical aesthetics industry in NigeriaBy Christy AnyanwuBimbola Ige, CEO of Celeb Laser and Aesthetics Clinic, shares her journey into the world of medical aesthetics, ...

GSK Pharmaceuticals Faces GST Demand Order

GlaxoSmithKline Pharmaceuticals Limited ( (IN:GLAXO) ) has shared an update.
The Pharma Letter

FDA approves two oral therapies to treat gonorrhea

The US Food and Drug Administration (FDA) on Friday announced it has approved two new oral medicines to treat a common ...
Managed Healthcare Executive

Low uptake of shingles vaccine despite strong value proposition for older adults

RZV offers substantial clinical and economic benefits but has low uptake among adults aged 50 and older compared to other vaccines. By 2020, only 10.8% of adults aged 50 and older had completed both ...
Medical Dialogues

GSK Nucala receives positive EMA Committee opinion for COPD

London: GSK has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency ...

Pharma major Dr. Reddy’s to produce and market drug for gonorrhoea granted approval by U.S. FDA

The FDA approves two new drugs for gonorrhoea treatment, with Dr. Reddy’s to market one in Thailand and South Africa.
Pharmabiz

EMA committee recommends approval of GSK’s RSV vaccine, Arexvy for all adults 18 years and older

EMA committee recommends approval of GSK’s RSV vaccine, Arexvy for all adults 18 years and older: London, UK Saturday, December 13, 2025, 13:00 Hrs [IST] GSK plc announced that ...
Medical Dialogues

GSK Blujepa gets USFDA approval as oral option for uncomplicated urogenital gonorrhoea

London: GSK has announced that the US Food and Drug Administration (FDA) has approved a supplemental New Drug Application for ...
Pharmabiz

US FDA approves GSK’s Blujepa as oral option for treatment of uncomplicated urogenital gonorrhoea

US FDA approves GSK’s Blujepa as oral option for treatment of uncomplicated urogenital gonorrhoea: London, UK Saturday, December 13, 2025, 09:00 Hrs [IST] GSK plc announced that ...